GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
2020-04-13 $3.70 $3.82 $3.57 $3.70 132 085
2020-04-09 $3.46 $3.71 $3.41 $3.63 121 659
2020-04-08 $3.25 $3.43 $3.22 $3.37 68 792
2020-04-07 $3.46 $3.55 $3.18 $3.20 176 245
2020-04-06 $3.10 $3.42 $3.10 $3.34 239 928
2020-04-03 $3.21 $3.29 $2.91 $3.00 112 883
2020-04-02 $3.00 $3.32 $2.86 $3.24 235 399
2020-04-01 $3.12 $3.21 $3.02 $3.05 170 629
2020-03-31 $3.25 $3.40 $3.06 $3.28 176 390
2020-03-30 $3.34 $3.39 $3.16 $3.28 134 529
2020-03-27 $3.40 $3.53 $3.27 $3.33 177 192
2020-03-26 $3.45 $3.76 $3.37 $3.61 139 700
2020-03-25 $3.25 $3.62 $3.18 $3.41 425 208
2020-03-24 $3.30 $3.38 $3.18 $3.25 169 191
2020-03-23 $3.00 $3.16 $2.80 $3.12 253 373
2020-03-20 $2.83 $3.00 $2.59 $2.91 267 122
2020-03-19 $2.34 $2.84 $2.34 $2.79 298 663
2020-03-18 $2.51 $2.58 $2.29 $2.36 220 074
2020-03-17 $2.60 $2.88 $2.31 $2.65 396 680
2020-03-16 $2.80 $3.58 $2.51 $2.53 524 802
2020-03-13 $3.34 $3.52 $2.94 $3.13 394 871
2020-03-12 $3.53 $3.70 $3.11 $3.16 358 767
2020-03-11 $3.77 $4.01 $3.76 $3.84 151 261
2020-03-10 $3.78 $4.06 $3.67 $3.97 330 938
2020-03-09 $4.00 $4.80 $3.75 $3.77 398 957
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT